跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,169 条关于
“SLTE-2100”
全部
6,169
临床试验
5,186
药物
489
机构
10
资讯
484
上个月
Fulcrum and Slate Medicines to Combine in Reverse Merger, Advancing Next-Generation Migraine Therapies
去年
Recode Therapeutics' RCT-2100 Shows Promise for Cystic Fibrosis Treatment
6个月前
Slate Medicines Secures $130M Series A to Advance Novel Anti-PACAP Migraine Therapy
6个月前
Slate Medicines Raises $130M to Develop Novel PACAP-Targeting Migraine Drug
去年
Biohaven Launches Phase 2 Trial of TRPM3 Antagonist BHV-2100 for Acute Migraine Treatment
去年
Biohaven Announces Third Quarter 2024 Financial Results and Business Developments
2年前
ArsenalBio Secures $325 Million in Series C Funding to Advance CAR T-Cell Therapies for Solid Tumors
去年
Blue Shield of California Slashes Humira Biosimilar Price by 75% Through Direct Purchase Model
去年
FDA Proposes Historic Nicotine Reduction in Tobacco Products to Combat Addiction
9个月前
Biohaven's BHV-1510 Shows Promising Early Cancer Data in Combination Trial
第 1 页,共 49 页
上一页
下一页